Tocqueville Asset Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-28,130
| Closed | -$365K | – | 793 |
|
|
2019
Q2 | $365K | Buy |
28,130
+5,425
| +24% | +$70.4K | ﹤0.01% | 654 |
|
|
2019
Q1 | $277K | Sell |
22,705
-1,980
| -8% | -$24.2K | ﹤0.01% | 687 |
|
|
2018
Q4 | $281K | Sell |
24,685
-375
| -1% | -$4.27K | ﹤0.01% | 638 |
|
|
2018
Q3 | $544K | Hold |
25,060
| – | – | 0.01% | 606 |
|
|
2018
Q2 | $443K | Buy |
25,060
+7,500
| +43% | +$133K | 0.01% | 629 |
|
|
2018
Q1 | $370K | Sell |
17,560
-6,500
| -27% | -$137K | ﹤0.01% | 667 |
|
|
2017
Q4 | $348K | Buy |
24,060
+11,735
| +95% | +$170K | ﹤0.01% | 674 |
|
|
2017
Q3 | $194K | Hold |
12,325
| – | – | ﹤0.01% | 778 |
|
|
2017
Q2 | $153K | Sell |
12,325
-1,000
| -8% | -$12.4K | ﹤0.01% | 763 |
|
|
2017
Q1 | $217K | Sell |
13,325
-1,800
| -12% | -$29.3K | ﹤0.01% | 739 |
|
|
2016
Q4 | $228K | Sell |
15,125
-76,650
| -84% | -$1.16M | ﹤0.01% | 739 |
|
|
2016
Q3 | $1.4M | Buy |
91,775
+5,600
| +6% | +$85.4K | 0.02% | 460 |
|
|
2016
Q2 | $3.35M | Buy |
86,175
+8,500
| +11% | +$330K | 0.04% | 346 |
|
|
2016
Q1 | $2.16M | Buy |
77,675
+500
| +0.6% | +$13.9K | 0.03% | 392 |
|
|
2015
Q4 | $4.15M | Buy |
77,175
+10,400
| +16% | +$559K | 0.06% | 309 |
|
|
2015
Q3 | $2.67M | Buy |
+66,775
| New | +$2.67M | 0.04% | 393 |
|